Beck Mack & Oliver LLC grew its stake in RadNet Inc. (NASDAQ:RDNT) by 0.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,067,039 shares of the medical research company’s stock after purchasing an additional 1,905 shares during the period. Beck Mack & Oliver LLC owned about 2.13% of RadNet worth $15,323,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. US Bancorp DE grew its position in RadNet by 34.0% in the 2nd quarter. US Bancorp DE now owns 3,325 shares of the medical research company’s stock worth $46,000 after purchasing an additional 844 shares during the last quarter. Envestnet Asset Management Inc. grew its position in RadNet by 11.0% in the 2nd quarter. Envestnet Asset Management Inc. now owns 11,390 shares of the medical research company’s stock worth $157,000 after purchasing an additional 1,132 shares during the last quarter. Northern Trust Corp grew its position in RadNet by 0.4% in the 2nd quarter. Northern Trust Corp now owns 528,414 shares of the medical research company’s stock worth $7,287,000 after purchasing an additional 1,885 shares during the last quarter. Aperio Group LLC acquired a new stake in RadNet in the 2nd quarter worth $36,000. Finally, Oppenheimer Asset Management Inc. acquired a new stake in RadNet in the 2nd quarter worth $40,000. Institutional investors own 62.67% of the company’s stock.
In related news, VP Mark Stolper sold 20,703 shares of RadNet stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $15.15, for a total transaction of $313,650.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Michael L. Md Sherman sold 30,000 shares of RadNet stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $15.19, for a total transaction of $455,700.00. Following the transaction, the director now directly owns 259,083 shares of the company’s stock, valued at $3,935,470.77. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by company insiders.
NASDAQ:RDNT opened at $16.14 on Tuesday. The company has a 50-day moving average of $14.97 and a 200-day moving average of $14.08. The company has a market capitalization of $797.02 million, a price-to-earnings ratio of 24.45, a PEG ratio of 6.42 and a beta of 0.86. RadNet Inc. has a 52 week low of $9.97 and a 52 week high of $16.66. The company has a debt-to-equity ratio of 5.09, a quick ratio of 0.80 and a current ratio of 0.80.
RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
Read More: How does new data get added to a blockchain?
Want to see what other hedge funds are holding RDNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RadNet Inc. (NASDAQ:RDNT).
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.